Dementia and motor neuron disease

Handbook of Clinical Neurology

Volumn 89, Issue , 2008, Pages 431-441

  Al Sarraj, Safa ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; PROTEIN TDP-43; TAR DNA BINDING PROTEIN; TAU PROTEIN; UBIQUITIN;

BRAIN; CLASSIFICATION; DEMENTIA; FRONTOTEMPORAL DEMENTIA; HUMAN; METABOLISM; MOTOR NEURON DISEASE; PATHOLOGY; REVIEW; ULTRASTRUCTURE;

BRAIN; DEMENTIA; DNA-BINDING PROTEINS; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; MOTOR NEURON DISEASE; TAU PROTEINS; UBIQUITIN;

EID: 66049105888     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(07)01239-0     Document Type: Review

References (79)

1. Al-Sarraj S., Maekawa S., Kibble M., et al. Ubiquitin-only intraneuronal inclusion in the substantia nigra is a characteristic feature of motor neurone disease with dementia. Neuropathol Appl Neurobiol 28 (2002) 120-128
2. Anderson V.E., Cairns N.J., and Leigh P.N. Involvement of the amygdala, dentate and hippocampus in motor neuron disease. J Neurol Sci 129 (1995) 75-78
3. Arai T., Nonaka T., Hasegawa M., et al. Neuronal and glial inclusions in frontotemporal dementia with or without motor neuron disease are immunopositive for p62. Neurosci Lett 342 (2003) 41-44
4. Bak T.H., and Hodges J.R. Cognition, language and behaviour in motor neurone disease: evidence of frontotemporal dysfunction. Dement Geriatr Cogn Disord 1 (1999) 29-32
5. Bak T.H., and Hodges J.R. Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum?. J Neurol 248 (2001) 260-270
6. Baker M., Mackenzie I.R., Pickering-Brown S.M., et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442 (2006) 916-919
7. Bergmann M., Kuchelmeister K., Migheli A., et al. Motor neuron disease with pallido-luysio-nigral atrophy. Acta Neuropathol (Berl) 86 (1993) 105-108
8. Bigio E.H., Johnson N.A., Rademaker A.W., et al. Neuronal ubiquitinated intranuclear inclusions in familial and non-familial frontotemporal dementia of the motor neuron disease type associated with amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 63 (2004) 801-811
9. Brown J. Chromosome 3-linked frontotemporal dementia. Cell Mol Life Sci 54 (1998) 925-927
10. Burrow J.N., and Blumbergs P.C. Substantia nigra degeneration in motor neurone disease: a quantitative study. Aust N Z J Med 22 (1992) 469-472
11. Chang H.T., Cortez S., Vonsattel J.P., et al. Familial frontotemporal dementia: a report of three cases of severe cerebral atrophy with rare inclusions that are negative for tau and synuclein, but positive for ubiquitin. Acta Neuropathol (Berl) 108 (2004) 10-16
12. Chow T.W., Miller B.L., Hayashi V.N., et al. Inheritance of frontotemporal dementia. Arch Neurol 56 (1999) 817-822
13. Cookson M.R., and Shaw P.J. Oxidative stress and motor neurone disease. Brain Pathol 9 (1999) 165-186
14. Cruts M., Gijselinck I., van der Zee J., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442 (2006) 920-924
15. Davidson Y., Kelly T., MacKenzie I., et al. Ubiquitinated pathological lesion in fronto-temporal lobar degeneration containing TAR-DNA binding protein TDP-43. Acta Neuropathol (Berl) 113 (2007) 521-533
16. Dickson D.W. Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases. Acta Neuropathol (Berl) 109 (2005) 14-24
17. Godbolt A.K., Josephs K.A., Revesz T., et al. Sporadic and familial dementia with ubiquitin-positive tau-negative inclusions: clinical features of one histopathological abnormality underlying frontotemporal lobar degeneration. Arch Neurol 62 (2005) 1097-1101
18. Hamilton R.L., and Bowser R. Alzheimer disease pathology in amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 107 (2004) 515-522
19. Hedera P., Lerner A.J., Castellani R., et al. Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis. J Neurol Sci 128 (1995) 219-224
20. Higashi S., Iseki E., Yamamoto R., et al. Concurrence of TDP-43, tau and alpha-synuclein pathology in brains of Alzheimer's disease and dementia with Lewy bodies. Brain Res 1184 (2007) 284-294
21. Holton J.L., Revesz T., Crooks R., et al. Evidence for pathological involvement of the spinal cord in motor neuron disease-inclusion dementia. Acta Neuropathol (Berl) 103 (2002) 221-227
22. Honig L.S., and Scarmeas N. Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia. Neurology 64 (2005) 1102 ; author reply 1102
23. Hosler B.A., Siddique T., Sapp P.C., et al. Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. Jama 284 (2000) 1664-1669
24. Ikemoto A., Hirano A., and Akiguchi I. Neuropathology of amyotrophic lateral sclerosis with extra-motor system degeneration: characteristics and differences in the molecular pathology between ALS with dementia and Guamanian ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 1 (2000) 97-104
25. Ince P.G., Lowe J., and Shaw P.J. Amyotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 24 (1998) 104-117
26. Ishigaki S., Hishikawa N., Niwa J., et al. Physical and functional interaction between Dorfin and Valosin-containing protein that is colocalized in ubiquitylated inclusions in neurodegenerative disorders. J Biol Chem 279 (2004) 51376-51385
27. Josephs K.A., Holton J.L., Rossor M.N., et al. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol Appl Neurobiol 30 (2004) 369-373
28. Katsuse O., and Dickson D.W. Ubiquitin immunohistochemistry of frontotemporal lobar degeneration differentiates cases with and without motor neuron disease. Alzheimer Dis Assoc Disord 19 (2005) S37-S43
29. Kawashima T., Furuta A., Doh-ura K., et al. Ubiquitin-immunoreactive skein-like inclusions in the neostriatum are not restricted to amyotrophic lateral sclerosis, but are rather aging-related structures. Acta Neuropathol (Berl) 100 (2000) 43-49
30. Kinoshita A., Tomimoto H., Tachibana N., et al. A case of primary progressive aphasia with abnormally ubiquitinated neurites in the cerebral cortex. Acta Neuropathol (Berl) 92 (1996) 520-524
31. Kinoshita A., Tomimoto H., Suenaga T., et al. Ubiquitin-related cytoskeletal abnormality in frontotemporal dementia: immunohistochemical and immunoelectron microscope studies. Acta Neuropathol (Berl) 94 (1997) 67-72
32. Kovari E., Gold G., Giannakopoulos P., et al. Cortical ubiquitin-positive inclusions in frontotemporal dementia without motor neuron disease: a quantitative immunocytochemical study. Acta Neuropathol (Berl) 108 (2004) 207-212
33. Kusaka H., and Hirano A. Cytopathology of the motor neuron. In: Younger D.S. (Ed). Motor Disorders (1999), Lippincott Williams & Wilkins, Philadelphia
34. Lipton A.M., White III C.L., and Bigio E.H. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol (Berl) 108 (2004) 379-385
35. Lloyd C.M., Richardson M.P., Brooks D.J., et al. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. Brain 123 (2000) 2289-2296
36. Lowe J. New pathological findings in amyotrophic lateral sclerosis. J Neurol Sci 124 (1994) 38-51
37. Lowe J. Establishing a pathological diagnosis in degenerative dementias. Brain Pathol 8 (1998) 403-406
38. Lowe J., and Rossor M.N. Frontotemporal lobar degeneration. In: Dickson D. (Ed). Neurodegeneration: The molecular pathology of dementia and movement disorders (2003), ISN Neuropath Press, Basel 342-348
39. Lowe J., Lennox G., Jefferson D., et al. A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin. Neurosci Lett 94 (1988) 203-210
40. Mackenzie I.R., and Feldman H. Neuronal intranuclear inclusions distinguish familial FTD-MND type from sporadic cases. Acta Neuropathol (Berl) 105 (2003) 543-548
41. Mackenzie I.R., and Feldman H. The relationship between extramotor ubiquitin-immunoreactive neuronal inclusions and dementia in motor neuron disease. Acta Neuropathol (Berl) 105 (2003) 98-102
42. Mackenzie I.R., and Feldman H. Extrapyramidal features in patients with motor neuron disease and dementia; a clinicopathological correlative study. Acta Neuropathol (Berl) 107 (2004) 336-340
43. Mackenzie I.R., Baker M., Pickering-Brown S., et al. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129 (2006) 3081-3090
44. Maekawa S., Al-Sarraj S., Kibble M., et al. Cortical selective vulnerability in motor neuron disease: A morphometric study. Brain 127 (2004) 1237-1251
45. Martin L.J., Price A.C., Kaiser A., et al. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review). Int J Mol Med 5 (2000) 3-13
46. Massoud F., Devi G., Stern Y., et al. A clinicopathological comparison of community-based and clinic-based cohorts of patients with dementia. Arch Neurol 56 (1999) 1368-1373
47. McCullagh S., Moore M., Gawel M., et al. Pathological laughing and crying in amyotrophic lateral sclerosis: An association with prefrontal cognitive dysfunction. J Neurol Sci 169 (1999) 43-48
48. Mizutani T., Aki M., Shiozawa R., et al. Development of ophthalmoplegia in amyotrophic lateral sclerosis during long-term use of respirators. J Neurol Sci 99 (1990) 311-319
49. Mizutani T., Sakamaki S., Tsuchiya N., et al. Amyotrophic lateral sclerosis with ophthalmoplegia and multisystem degeneration in patients on long-term use of respirators. Acta Neuropathol (Berl) 84 (1992) 372-377
50. Morris H.R., Al-Sarraj S., Schwab C., et al. A clinical and pathological study of motor neurone disease on Guam. Brain 124 (2001) 2215-2222
51. Nakano T., Nakaso K., Nakashima K., et al. Expression of ubiquitin-binding protein p62 in ubiquitin-immunoreactive intraneuronal inclusions in amyotrophic lateral sclerosis with dementia: analysis of five autopsy cases with broad clinicopathological spectrum. Acta Neuropathol (Berl) 107 (2004) 359-364
52. Neary D., Snowden J.S., and Mann D.M. Classification and description of frontotemporal dementias. Ann N Y Acad Sci 920 (2000) 46-51
53. Neumann M., Sampathu D.M., Kwong L.K., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 (2006) 42-43
54. Nihei K., McKee A.C., and Kowall N.W. Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients. Acta Neuropathol (Berl) 86 (1993) 55-64
55. Okamoto K. Temporal lobe pathology in patients with amyotrophic lateral sclerosis. Neuropathology 18 (1998) 222-227
56. Okamoto K., Murakami N., Kusaka H., et al. Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease. J Neurol 239 (1992) 426-430
57. Park I., Chung J., Walsh C.T., et al. Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. Proc Natl Acad Sci USA 92 (1995) 12338-12342
58. Parkinson N., Ince P.G., Smith M.O., et al. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein). Neurology 67 (2006) 1074-1077
59. Qureshi A.I., Wilmot G., Dihenia B., et al. Motor neuron disease with parkinsonism. Arch Neurol 53 (1996) 987-991
60. Ratnavalli E., Brayne C., Dawson K., et al. The prevalence of frontotemporal dementia. Neurology 58 (2002) 1615-1621
61. Ringholz G.M., Appel S.H., Bradshaw M., et al. Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65 (2005) 586-590
62. Rosso S.M., Donker Kaat L., Baks T., et al. Frontotemporal dementia in The Netherlands: Patient characteristics and prevalence estimates from a population-based study. Brain 126 (2003) 2016-2022
63. Rosso S.M., Kamphorst W., de Graaf B., et al. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 124 (2001) 1948-1957
64. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 344 (2001) 1688-1700
65. Sanelli T., Xiao S., Horne P., et al. Evidence that TDP-43 is not the major ubiquitinated target within the pathological inclusions of amyotrophic lateral sclerosis. J Neuropathology Exp Neurol. 66 (2007) 1147-1153
66. Schiffer D., Autilio-Gambetti L., Chio A., et al. Ubiquitin in motor neuron disease: study at the light and electron microscope. J Neuropathol Exp Neurol 50 (1991) 463-473
67. Skibinski G., Parkinson N.J., Brown J.M., et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 37 (2005) 806-808
68. Su M., Yoshida Y., Ishiguro H., et al. Nigral degeneration in a case of amyotrophic lateral sclerosis: Evidence of Lewy body-like and skein-like inclusions in the pigmented neurons. Clin Neuropathol 18 (1999) 293-300
69. Takahashi H., Oyanagi K., Ohama E., et al. Clarke's column in sporadic amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 84 (1992) 465-470
70. Takahashi H., Oyanagi K., and Ikuta F. The intermediolateral nucleus in sporadic amyotrophic lateral sclerosis. Acta Neuropathol (Berl) 86 (1993) 190-192
71. Tan C., Eguchi H., Tagawa A., et al. Acta Neuropathol (Berl) (2007)
72. Tolnay M., and Probst A. Frontal lobe degeneration: novel ubiquitin-immunoreactive neurites within frontotemporal cortex. Neuropathol Appl Neurobiol 21 (1995) 492-497
73. Toyoshima Y., Piao Y.S., Tan C.F., et al. Pathological involvement of the motor neuron system and hippocampal formation in motor neuron disease-inclusion dementia. Acta Neuropathol (Berl) 106 (2003) 50-56
74. Tsuchiya K., Matsunaga T., Aoki M., et al. Familial amyotrophic lateral sclerosis with posterior column degeneration and basophilic inclusion bodies: a clinical, genetic and pathological study. Clin Neuropathol 20 (2001) 53-59
75. Turner M.R., Rabiner E.A., Hammers A., et al. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS. Brain 128 (2005) 896-905
76. Vadlamudi R.K., Joung I., Strominger J.L., et al. P62, a phosphotyrosine-independent ligand of the SH2 domain of p56lck, belongs to a new class of ubiquitin-binding proteins. J Biol Chem 271 (1996) 20235-20237
77. Wilhelmsen K.C., Forman M.S., Rosen H.J., et al. 17q-linked frontotemporal dementia-amyotrophic lateral sclerosis without tau mutations with tau and alpha-synuclein inclusions. Arch Neurol 61 (2004) 398-406
78. Yaguchi M., Fujita Y., Amari M., et al. Morphological differences of intraneuronal ubiquitin-positive inclusions in the dentate gyrus and parahippocampal gyrus of motor neuron disease with dementia. Neuropathology 24 (2004) 296-301
79. Yoshida M. Amyotrophic lateral sclerosis with dementia: The clinicopathological spectrum. Neuropathology 24 (2004) 87-102